Celecoxib to prevent polyps from growing in Peutz-Jeghers Syndrome
Treatments studied
Part of Cancer, Digestive system, Genetic & congenital, Skin clinical trials.
This trial is testing if the medication celecoxib can stop or slow the growth of polyps in people with Peutz-Jeghers Syndrome (PJS). It may help reduce the need for surgery and lower the risk of complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 8 years or older
- You have been diagnosed with Peutz-Jeghers Syndrome
- You have not taken any NSAID pain relievers (like aspirin or ibuprofen) in the last 6 months, or you are willing to stop for 3 months before starting the study
- You do not have large polyps (3 cm or bigger) in your small intestine based on recent imaging
- You have not had surgery for small intestine polyps in the past 2 years and do not plan to in the next 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of two drugs, celecoxib and metformin, can prevent the growth of polyps in the colon or duodenum (the first part of the small intestine) in people with familial adenomatous polyposis (FAP). FAP is a condition that causes many polyps to form, raising the risk of cancer. If you have FAP, are between 20 and 55, and have at least 5 polyps that are 2mm or larger, this study may be for you.
This study tests whether adding celecoxib (an anti-inflammatory drug) to standard immunotherapy and chemotherapy improves outcomes for people with a specific type of bile duct cancer that has high levels of a protein called CK5/6. It aims to see if the combination is safe and effective.
This trial studies how celecoxib moves through a child’s body and how much reaches the fluid around the brain and spinal cord. It’s for children (age 2–12) who are in the maintenance phase of certain blood cancers, to better understand dosing and safety.
This research study tests whether adding a drug called celecoxib (an anti-inflammatory pill) can help treat early-stage triple-negative breast cancer after surgery, before or during radiation therapy. You may be eligible if your cancer was removed cleanly and you do not have other health issues like stomach ulcers, kidney problems, or a history of allergic reactions to certain pain relievers.
This trial tests if adding celecoxib, an anti-inflammatory drug, to standard Parkinson's treatment can help improve symptoms. If you have Parkinson's disease and are at least 18, this study might be an option for you.
This early-phase trial studies REC-4881 in adults with familial adenomatous polyposis (FAP), a condition that causes many colon/rectum and duodenal polyps. It aims to see whether the treatment can safely help control or shrink polyp growth in people who have had bowel surgery.
Hear when a new Peutz-Jeghers Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.